Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 52,500 shares, an increase of 16.7% from the March 15th total of 45,000 shares. Based on an average daily trading volume, of 17,900 shares, the days-to-cover ratio is presently 2.9 days.

Apollomics Price Performance

Shares of NASDAQ APLMW remained flat at $0.01 during midday trading on Monday. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.13. The company’s 50-day moving average price is $0.03 and its 200-day moving average price is $0.03.

Institutional Investors Weigh In On Apollomics

A number of hedge funds and other institutional investors have recently modified their holdings of APLMW. Ionic Capital Management LLC acquired a new stake in shares of Apollomics in the first quarter worth approximately $30,000. Shaolin Capital Management LLC acquired a new stake in shares of Apollomics in the first quarter worth approximately $33,000. Finally, ATW Spac Management LLC acquired a new stake in shares of Apollomics in the first quarter worth approximately $39,000.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.